What Medifarma does

Medifarma S.A. is a privately held Peruvian pharmaceutical manufacturer founded in 1964, operating as a Sociedad Anónima with headquarters in Lima. The company is positioned among the top 3 pharmaceutical laboratories in Peru and claims the #1 position in sales among national-capital (domestically owned) laboratories. Its portfolio spans approximately 1,000 registered products across therapeutic categories including antibiotics, oncology, ophthalmology, nephrology, respiratory, digestive, contraceptives, and personal care, with sub-brands such as HYLO-COMOD (preservative-free ocular lubricant), LEGEND (condoms and lubricants), EVAKUA (laxatives), ELECTROLIGHT (hydration beverages), and Dr. Zaidman (baby care). The company manufactures across multiple dosage forms — solids, semi-solids, liquids, parenteral solutions, injectables, beta-lactams, cephalosporins, and sterile oncological products — through 6 international production plants covering more than 70,000 m2, all operating under Good Manufacturing Practices compliance.

The company generates revenue through one-time sales of branded pharmaceutical and consumer health products, distributed via three primary channels in Peru (private healthcare providers, public institutions, and retail pharmacies) plus international subsidiaries and commercial offices. Its geographic footprint spans 5 countries: Peru (headquarters and core market), Uruguay (Fármaco Uruguayo, founded 1976, with oncology and parenteral solutions manufacturing), Brazil (Farmarin, founded 1988, nephrology specialist in Guarulhos), Ecuador (commercial office since 2012), and Paraguay (FUSA S.A. sales office). Customers include healthcare professionals, retail consumers, public and private healthcare institutions, and distribution partners. The GTM motion combines direct enterprise sales, channel partnerships via regional subsidiaries, and distribution through retail pharmacies and drugstores across Latin American markets.

Medifarma's business model is centered on in-house pharmaceutical manufacturing with a diversified portfolio strategy, supplemented by selective technology partnerships (e.g., German ophthalmological technology provider for HYLO-COMOD) and acquisition-led regional expansion over its 50+ year history. The company maintains a pharmacovigilance and technovigilance unit, holds multiple product registrations and brand identity records, and operates compliance infrastructure including a formal Code of Conduct and ethics line. Revenue is not publicly disclosed and the company has no external venture, private equity, or public market investors identified in available data, indicating retained private ownership under domestic Peruvian control.

Name

Medifarma

Legal name

MEDIFARMA S.A.

Website

https://medifarma.com.pe

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Medifarma is a privately held Peruvian pharmaceutical manufacturer founded in 1964, operating the #1 national-capital pharmaceutical laboratory in Peru. It produces approximately 1,000 branded pharmaceutical and consumer health products across 6 plants in 5 Latin American countries, serving healthcare professionals, patients, and institutions.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Ophthalmic Goods (3851), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Ophthalmology Pharmaceuticals (HLAIAAAL), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

Keywords

• Pharmaceutical manufacturing
• Branded medications
• Personal care products
• Ophthalmological products
• Oncology and nephrology

Headquarters

HQ city

Lima

HQ country

Peru

HQ region

Latin America

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products: Development and sale of branded pharmaceutical medications covering multiple therapeutic areas including antibiotics, digestive line, contraceptives, respiratory line, ophthalmological products, and specialty medications.
2. Personal Care Products: Consumer healthcare products including baby care line (Dr. Zaidman), ophthalmological products (HYLO-COMOD), contraceptives and lubricants (Legend), and hydration beverages (Electrolight).
3. Nephrology Products: Specialized nephrology products through Farmarin subsidiary in Brazil including CPHD Basic, CPHD Acid, Farmacart, and Farmastéril for dialysis treatment.
4. Oncology Products: Specialized oncology medications produced in Uruguay, with Farmaco Uruguayo operating the first plant in Uruguay specifically designed for cancer medication production.
5. Parenteral Solutions: Large volume parenteral solutions, small volume injectables, and concentrates for hemodialysis through Farmaco Uruguayo operations in Uruguay.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

Medifarma develops, manufactures, and distributes a portfolio of nearly 1,000 branded pharmaceutical and personal care products across multiple therapeutic areas, including antibiotics, digestive, respiratory, ophthalmological, oncology, and nephrology medications, alongside consumer brands such as HYLO-COMOD eye drops, LEGEND contraceptives, EVAKUA laxatives, ELECTROLIGHT hydration drinks, and Dr. Zaidman baby care. The company operates 6 production plants across Peru, Uruguay, and Brazil, and sells through private, public, and retail channels in 5 Latin American countries.

Product overview

MEDIFARMA S.A. is a Peruvian pharmaceutical company operating since 1964 that manufactures and distributes pharmaceutical and personal care products. The company operates as a unified portfolio organized around core pharmaceutical manufacturing capabilities supplemented by consumer health sub-brands. Key products include the HYLO-COMOD preservative-free ocular lubricant, LEGEND condoms and lubricants, EVAKUA Perlas and Limonada Purgante laxatives, ELECTROLIGHT electrolyte beverages, and Dr. ZAIDMAN baby care line. Through subsidiaries FARMACO URUGUAYO (Uruguay) and FARMARIN (Brazil), the company also offers hemodialysis solutions, parenteral solutions, and oncology products. MEDIFARMA holds approximately 1,000 product registrations distributed through private, public, and retail channels, with 6 production plants covering over 70,000 m2 across multiple countries.

Differentiator

Problem solved

Functional benefit

Brands

• Corporación Medifarma: Corporate group name used on LinkedIn and international operations.
• LEGEND
• HYLO-COMOD
• EVAKUA
• DR. ZAIDMAN
• ELECTROLIGHT

Products and services

• Pharmaceutical Products Portfolio Core pharmaceutical product portfolio covering multiple therapeutic areas including antibiotics, digestive, respiratory, contraceptives, oncology, and specialty medications manufactured and distributed across Peru and Latin America.
• HYLO-COMOD Preservative-free ocular lubricant containing sodium hyaluronate for dry eye syndrome treatment, using the German-made COMOD multi-dose system.
• LEGEND Brand of condoms and personal lubricants in multiple presentations (Clásico, Sensitivo, Aros, Espuelas, Retardante) targeted at consumer retail.
• EVAKUA Perlas Soft gel capsule laxative for constipation treatment, the only soft gel capsule laxative on the Peruvian market.
• EVAKUA Limonada Purgante Laxative/purgative lemonade product part of the Evakua constipation treatment line.
• ELECTROLIGHT Hydrating electrolyte beverage available in Manzana (apple) and Mora (berry) 475ml presentations for rehydration.
• Dr. Zaidman Baby care product line including anti-scald cream, liquid and bar soaps, shampoos, colognes, talcs, oils, and wet wipes.
• FARMACO URUGUAYO Products Pharmaceutical product line from Uruguayan subsidiary Farmaco Uruguayo including large volume parenteral solutions, hemodialysis concentrates, small volume injectables, analgesia tablets, and oncology medications.
• FARMARIN Nephrology Products Nephrology product line from Brazilian subsidiary Farmarin including CPHD Basic, CPHD Acid, Farmacart, and Farmasteril products for dialysis treatment.

Quantifiable outcome

• Leading pharmaceutical market position in Peru as #1 national capital laboratory
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Medifarma EcuadorcoreOthers · 1 January 2012Commercial office in Quito, Ecuador operating since 2012. Markets antibiotics, digestive line products, contraceptives, serums, hemodialysis concentrates, and respiratory line products.
• Farmarin Industria e Comercio LtdacoreOthers · 1 January 1988Subsidiary founded in 1988, specializing in nephrology products. Located in Guarulhos, São Paulo, Brazil since 2000. Products include CPHD Basic, CPHD Acid, Farmacart, and Farmastéril. Currently expanding infrastructure for new product launches.
• Farmaco Uruguayo (FU)coreOthers · 1 January 1976Subsidiary founded in 1976 located in Montevideo, Uruguay. Houses three production plants including the first in Uruguay specifically designed for oncology medication production. Main product lines include large volume parenteral solutions, hemodialysis concentrates, small volume injectables, tablets, and oncology products. Approximately 50% local sales, 50% export.
• FUSA S.A. (Paraguay)minorOthersSales office in Asunción, Paraguay operated by FUSA S.A., representing Farmaco Uruguayo distribution in the Paraguayan market.
• German Ophthalmological Technology Provider (HYLO-COMOD)coreTechnology or IntegrationPartnership for HYLO-COMOD preservative-free ocular lubricant. Manufactured in Germany with innovative COMOD system technology offering 300 drops per 10ml, 6-month stability, and absolute sterility. Distributed by MEDIFARMA in Peru.
• Healthcare ProfessionalscoreStrategic or Co-development PartnerStrategic allies who identify and recommend high-quality pharmaceutical products for patient treatment. MEDIFARMA provides training and educational materials on treatments and health products.
• Distributors and Points of SalecoreChannel Partner/ Reseller/ DistributorDistribution partners enabling MEDIFARMA products to reach establishments and geographic areas not directly served by the company.
• Private and Public Healthcare InstitutionscoreStrategic or Co-development PartnerHealthcare institutions that provide MEDIFARMA products to patients through their healthcare networks.
• SupplierscoreOthersProvide quality inputs, equipment, and specialized technical services to support MEDIFARMA's pharmaceutical manufacturing operations.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Genomma Lab: Latin American pharmaceutical company focused on branded OTC and personal care products across multiple countries. Comparable to Medifarma's consumer health sub-brands (Dr. Zaidman, Electrolight, Evakua) and multi-country retail distribution.
• Laboratorios Bagó: Argentine-founded multinational pharmaceutical company with strong presence across Latin America in branded generics and specialty therapeutics. Directly comparable to Medifarma in multi-country LatAm footprint, branded pharma focus, and family-owned private ownership structure.
• Asofarma: Mexican pharmaceutical company with international presence across Latin America and broad branded specialty portfolio. Comparable to Medifarma in multi-country LatAm manufacturing and specialty pharma focus.
• Roemmers: Major Argentine pharmaceutical company with broad branded portfolio across therapeutic categories and multi-country Latin American operations. Directly comparable to Medifarma in family-owned Latin American pharma model and diversified therapeutic reach.
• Gador: Argentine pharmaceutical company with multi-country Latin American presence and broad branded product portfolio. Comparable to Medifarma in regional Latin American pharma manufacturing and distribution model.
• Eurofarma: Brazilian pharmaceutical company with operations across Latin America, manufacturing branded generics, specialty products, and OTC. Comparable in scale, geographic diversification, and branded pharma manufacturing business model.
• Procaps: Colombian pharmaceutical company with branded generics, specialty therapeutics, and consumer health products across Latin America. Comparable to Medifarma in regional pharma manufacturing with branded portfolio across multiple therapeutic categories.
• Biolab: Brazilian pharmaceutical company with branded specialty portfolio in cardiology, gynecology, and dermatology with expanding international presence. Comparable to Medifarma's specialty pharma positioning and regional Latin American growth strategy.

Broad incumbents

• Alcon: Global ophthalmology leader that markets competing ocular lubricants and eye care products. Comparable to Medifarma's HYLO-COMOD product line in ophthalmology category, though operating at much larger scale.
• EMS Pharma: Largest Brazilian pharmaceutical company by units sold, with broad branded generic and specialty portfolio across Latin America. Comparable in diversified therapeutic manufacturing and multi-country reach, though larger in scale than Medifarma.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medifarma-s.a.
• Facebookfacebook.com/MedifarmaSa

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medifarma